Carregant...
Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation
Post-hoc subgroup analysis of the negative trial of interleukin-1β receptor antagonist (IL1RA) for septic shock suggested that patients with features of macrophage activation syndrome (MAS) experienced a 50% relative risk reduction for mortality with treatment. Here we seek a genetic basis for this...
Guardat en:
| Publicat a: | Genes Immun |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6320733/ https://ncbi.nlm.nih.gov/pubmed/29977033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41435-018-0030-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|